• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients?

作者信息

Barosi G, Tefferi A, Barbui T

出版信息

Leukemia. 2012 May;26(5):1148-9. doi: 10.1038/leu.2011.337. Epub 2011 Nov 22.

DOI:10.1038/leu.2011.337
PMID:22105597
Abstract
摘要

相似文献

1
Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients?经典的Ph阴性骨髓增殖性肿瘤的当前反应标准是否能让患者获益？
Leukemia. 2012 May;26(5):1148-9. doi: 10.1038/leu.2011.337. Epub 2011 Nov 22.
2
[Summary of recommendations for the diagnosis and therapy of BCR/ABL-negative myeloproliferation of the Czech Working Group for Ph-negative myeloproliferative disease (CZEMP) of the Czech Hematologic Society CLS JEP ].
Vnitr Lek. 2012 Feb;58(2):163-8.
3
Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide.真性红细胞增多症演变为一种进展迅速的Ph阴性、del(5q)阳性的骨髓增殖性肿瘤，对来那度胺耐药。
Leuk Res. 2011 May;35(5):e41-3. doi: 10.1016/j.leukres.2011.01.005. Epub 2011 Feb 1.
4
Philadelphia chromosome-negative myeloproliferative disorders: biology and treatment.费城染色体阴性骨髓增殖性疾病：生物学与治疗
Biol Blood Marrow Transplant. 2007 Jan;13(1 Suppl 1):64-72. doi: 10.1016/j.bbmt.2006.11.003.
5
Incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the Côte d'Or area, France, during 1980-99.
J Intern Med. 2005 Jul;258(1):90-1. doi: 10.1111/j.1365-2796.2005.01505.x.
6
[Unclassified chronic myeloproliferative disorder (Ph negative/bcr rearrangement negative CML) with late appearing Philadelphia like chromosome].
Rinsho Ketsueki. 1996 Mar;37(3):221-7.
7
Philadelphia chromosome-negative chronic myeloproliferative disease.费城染色体阴性慢性骨髓增殖性疾病
Am J Clin Pathol. 2009 Aug;132(2):261-80. doi: 10.1309/AJCPR8GINMBDG9YG.
8
Pregnancy and its management in the Philadelphia negative myeloproliferative diseases.费城阴性骨髓增殖性疾病中的妊娠及其管理
Br J Haematol. 2005 May;129(3):293-306. doi: 10.1111/j.1365-2141.2005.05400.x.
9
[Glivek in the therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome].[格列维克在某些类型的Ph阴性和bcr/abl阴性骨髓增殖性疾病以及特发性嗜酸性粒细胞增多综合征的骨髓增殖性变异型治疗中的应用]
Ter Arkh. 2004;76(7):87-90.
10
How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms.我如何治疗费城染色体阴性骨髓增殖性肿瘤的急变期。
Blood. 2018 Nov 29;132(22):2339-2350. doi: 10.1182/blood-2018-03-785907. Epub 2018 Oct 17.

引用本文的文献

1
How can we know if new drugs are effective in myeloproliferative neoplasm-associated myelofibrosis?我们如何才能知道新药在骨髓增殖性肿瘤相关的骨髓纤维化中是否有效？
Leukemia. 2016 Jul;30(7):1453-5. doi: 10.1038/leu.2016.75. Epub 2016 Apr 29.
2
Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study.在评估Xagrid（R）疗效和长期安全性研究中，羟基脲与阿那格雷联合治疗原发性血小板增多症患者。
Haematologica. 2014 Apr;99(4):679-87. doi: 10.3324/haematol.2012.083097. Epub 2013 Dec 13.
3
Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.
修订版原发性骨髓纤维化、真性红细胞增多症和原发性血小板增多症的反应标准：ELN 和 IWG-MRT 共识项目。
Blood. 2013 Jun 6;121(23):4778-81. doi: 10.1182/blood-2013-01-478891. Epub 2013 Apr 16.